Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Immunotherapy in Melanoma

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Immunotherapy in Melanoma

Novel Combo Elicits Clinical Responses in Patients With "Cold" Melanomas

Combining the PD-1 inhibitor pembrolizumab with intratumoral plasmid interkeukin-12 electroporation elicited clinical responses in patients with immunologically quiescent advanced melanoma.
Read More >>

Algazi Attests to Benefit of Continuous Dosing of BRAF/MEK Inhibitors in Melanoma

Cemiplimab Shows Strong Activity in Pivotal Basal Cell Carcinoma Trial

Neoadjuvant Nivolumab Shows Strong Clinical Activity in Merkel Cell Carcinoma

AACR 2020: Atezolizumab Plus Vemurafenib/Cobimetinib Impresses in BRAF V600+ Melanoma

AACR 2020: Continuous Dabrafenib/Trametinib Dosing Improves PFS in BRAF+ Melanoma

View More Stories >>

View Conference Coverage

2020 ESMO Breast Cancer Virtual Meeting

2020 ASCO Virtual Scientific Program

2020 International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

2020 AACR Annual Meeting

2020 SGO Annual Meeting

Dr. Sznol on the Use of Immunotherapy in Melanoma

Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC

Dr. Pavlick on the COLUMBUS Trial in Metastatic Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Immune Checkpoint Inhibitors for AML

Checkpoint Inhibitors in Second and Third-line

Unmet Needs and Future Treatments of Metastatic Melanoma

The Use of Dual Targeted Therapy in Metastatic Melanoma

$Management of Relapsed/Refractory Metastatic Melanoma$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

Emerging Treatment Strategies for Advanced BRAF+ Melanoma

Sequencing Therapy in Metastatic BRAF+ Melanoma

Selecting Therapy & Managing Patients With BRAF+ Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

OncLive Saturday Spotlight: A Morning With NYU Langone Perlmutter Cancer Center

The OncLive Saturday Spotlight webinars feature a panel of top physicians from one of our nation’s leading institutions. This week we have collaborated with NYU Langone Health to highlight important topics facing oncologists today. View Now

Dr. Hodi on Long-Term Survival Data for Nivolumab in Melanoma

F. Stephen Hodi, MD, director of the Melanoma Center at Dana-Farber Cancer Institute, and investigator at the Ludwig Center at Harvard, discusses the results of a 5-year follow-up analysis of survival outcomes of patients with advanced melanoma who were treated with single-agent nivolumab (Opdivo).

View Now

Featured Webinar

Live Broadcast on Metastatic Triple-Negative Breast Cancer